Robert Grossberg

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial”.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00384-2

N/A

4.4DataRank · unranked

167 citations

Aneesh K Mehta, Thomas F Patterson, Nathaniel Erdmann, Carlos A Gomez, Mamta K Jain +95 more

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00088-1

N/A

3.0DataRank · unranked

128 citations

Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez, Vincent C. Marconi, Mamta K. Jain +95 more

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae198

N/A

0.439DataRank · unranked

13 citations

Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin Dewar +94 more

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

Annals of Internal Medicine(2022)10.7326/m22-2116

N/A

0.434DataRank · unranked

6 citations

Tyler Bonnett, Kevin Rubenstein, David A Lindholm, Rekha R. Rapaka, Sarah B. Doernberg +39 more

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2

Annals of Internal Medicine(2024)10.7326/m23-2593

N/A

0.376DataRank · unranked

6 citations

Jing Wang, Kay M. Tomashek, Tyler Bonnett, Kanal Singh, Vincent C. Marconi +16 more

Abstinence-reinforcing contingency management improves HIV viral load suppression among HIV-infected people who use drugs: A randomized controlled trial

Drug and Alcohol Dependence(2020)10.1016/j.drugalcdep.2020.108230

N/A

0.330DataRank · unranked

8 citations

Julia H. Arnsten, Chenshu Zhang, Moonseong Heo, Marcus A. Bachhuber, John J. Jost +4 more

Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad290

N/A

0DataRank · unranked

2 citations

Noreen A. Hynes, Corri B. Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg +37 more

Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data

Clinical Infectious Diseases(2021)10.1093/cid/ciab695

N/A

0DataRank · unranked

17 citations

Shannon Gallagher, Rekha R. Rapaka, Richard T. Davey, Sarah B. Doernberg, Robert Grossberg +11 more